These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2532290)

  • 21. Optimal fluorescein-to-protein ratios of bacterial direct fluorescent-antibody reagents.
    Hébert GA; Pittman B; McKinney RM
    J Clin Microbiol; 1981 Mar; 13(3):498-502. PubMed ID: 6165737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of an apparent germline set of auto-anti-idiotypic regulatory B lymphocytes.
    Pollok BA; Kearney JF
    J Immunol; 1984 Jan; 132(1):114-21. PubMed ID: 6606663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unscheduled DNA synthesis in human lymphocytes treated with neocarzinostatin.
    Tatsumi K; Sakane T; Sawada H; Shirakawa S; Nakamura T
    Gan; 1975 Aug; 66(4):441-4. PubMed ID: 126891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG.
    Ma J; Chapman GV; Chen SL; Melick G; Penny R; Breit SN
    Clin Exp Immunol; 1991 Apr; 84(1):83-91. PubMed ID: 1901780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.
    Harata N; Sasaki T; Osaki H; Saito T; Shibata S; Muryoi T; Takai O; Yoshinaga K
    J Clin Invest; 1990 Sep; 86(3):769-76. PubMed ID: 2144300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular FITC-linked immunospecific assay (cell-FLISA) for detection of monoclonal antibodies against cell-surface antigens.
    Okumura N; Aosai F; Yui K; Yamashita K; Yabu K; Kanai M; Yano A
    Hum Immunol; 1986 Jan; 15(1):97-108. PubMed ID: 2419287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies.
    Mahana W; Guilbert B; Avrameas S
    Clin Exp Immunol; 1987 Dec; 70(3):538-45. PubMed ID: 3501743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA.
    Hahn BH; Ebling FM
    J Immunol; 1984 Jan; 132(1):187-90. PubMed ID: 6606665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic effect of neocarzinostatin on human lymphoid cells.
    Maeda H; Matsumoto M
    Tohoku J Exp Med; 1979 Aug; 128(4):313-23. PubMed ID: 225845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of anti-neocarzinostatin (NCS) antibody production in leukemia patients treated with NCS.
    Toki H
    Acta Med Okayama; 1976 Apr; 30(2):135-42. PubMed ID: 135485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of chromosome damage and sister-chromatid exchanges in human lymphocyte cultures by the antitumour antibiotic Neocarzinostatin.
    Psaraki K; Demopoulos NA
    Mutat Res; 1988 Apr; 204(4):669-73. PubMed ID: 2965299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of affinities of murine and chimeric anti alpha/beta-T-cell receptor antibodies by flow cytometry.
    Krause D; Shearman C; Lang W; Kanzy EJ; Kurrle R
    Behring Inst Mitt; 1990 Dec; (87):56-67. PubMed ID: 2129005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome aberrations induced by neocarzinostatin in cultured human lymphocytes.
    Tsuda S
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):65-78. PubMed ID: 2954359
    [No Abstract]   [Full Text] [Related]  

  • 34. Two-color flow cytometric techniques as a diagnostic tool for rejection of renal transplantation.
    Hayashi R; Sakakibara I; Suzuki S; Amemiya H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1603-4. PubMed ID: 3152631
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression and synthesis of cross-reactive idiotypic antibodies by peripheral blood lymphocytes and their suppression by anti-idiotypes in patients with IgA nephropathy.
    González-Cabrero J; de Nicolas R; Hernando L; Egido J
    J Immunol; 1991 Dec; 147(12):4162-6. PubMed ID: 1753092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular action of Neocarzinostatin. Intracellular incorporation, DNA breakdown and cytotoxicity.
    Takeshita J; Maeda H; Koike K
    J Biochem; 1980 Oct; 88(4):1071-80. PubMed ID: 6256337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.
    Otsuji E; Tsuruta H; Toma A; Kobayashi S; Okamoto K; Yata Y; Yamagishi H
    Hepatogastroenterology; 2003; 50(50):380-4. PubMed ID: 12749227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of neocarzinostatin on hemolytic plaque-forming cell production in mice.
    Takahashi I; Mikochi H; Sakato J; Nakanishi T; Toki H
    Acta Med Okayama; 1975 Aug; 29(4):327-8. PubMed ID: 128994
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of protein A in the detection and quantitation of immunoglobulin G on the surface of lymphocytes.
    Ghetie V; Sjöquist J
    Methods Enzymol; 1984; 108():405-13. PubMed ID: 6441880
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of anti-DNA autoanti-idiotypic antibodies in (NZB X NZW)F1 mice: possible role for specific immune suppression.
    Jacob L; Tron F
    Clin Exp Immunol; 1984 Nov; 58(2):293-9. PubMed ID: 6333943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.